EN
FR
Contact Us
Donate

MENUMENU

Lymphoma
Patient Experience
Resources
News & Events
Get Involved
Ways to Give
About Us
Know Your Nodes

Lymphoma
Patient Experience
Resources
News & Events
Get Involved
Ways to Give
About Us
Know Your Nodes

Research

Health Canada Approves ibrutinib for Mantle Cell Lymphoma

News Research

Health Canada Approves ibrutinib for Mantle Cell Lymphoma

Specific subtype of diffuse large B-cell lymphoma more likely to respond to ibrutinib

News Research

Specific subtype of diffuse large B-cell lymphoma more likely to respond to ibrutinib

Aggressive lymphoma linked to disruption in cell energy production

News Research

Aggressive lymphoma linked to disruption in cell energy production

Understanding risks and managing expectations around relapse

Research

Understanding risks and managing expectations around relapse

European Hematology Association Congress 2015

resizedimage250151-eha20-anniversary-viennargb-internettransp

News Research

European Hematology Association Congress 2015

2013 Research Fellowship – Progress Update

News Research

2013 Research Fellowship – Progress Update

Y-ibritumomab tiuxetan and high-dose BEAM chemotherapy conditioning followed by autologous stem cell transplantation shows encouraging response and survival rates in refractory diffuse large B-cell lymphoma patients

Research

Y-ibritumomab tiuxetan and high-dose BEAM chemotherapy conditioning followed by autologous stem cell transplantation shows encouraging response and survival rates in refractory diffuse large B-cell lymphoma patients

Potential Role of Lymphocyte Development Gene Variants in Non-Hodgkin Lymphoma Risk

Research

Potential Role of Lymphocyte Development Gene Variants in Non-Hodgkin Lymphoma Risk

Rituximab helps overcome adverse effects of diabetes mellitus for patients with diffuse large B-cell lymphoma. masthead_ph_shadows

Research

Rituximab helps overcome adverse effects of diabetes mellitus for patients with diffuse large B-cell lymphoma.

LR11: a novel biomarker identified in follicular lymphoma

Research

LR11: a novel biomarker identified in follicular lymphoma

Search

Are you a patient?

Get Informed

Are you a healthcare professional?

See Resources

Contact Us

Lymphoma Canada
6860 Century Avenue, Suite 202
Mississauga, ON L5N 2W5
Telephone 905.858.5967
Toll Free: 1.866.659.5556
General inquiries: info@lymphoma.ca
Charitable Number: 873461040RR0001

Donate

With your support, no one will have to face lymphoma alone. You can make a difference!
Donate

Careers

Join Our Mailing List

First Name *

Last Name *

Email Address *

Preferred Language

English
French

YouTube
X
Facebook
Instagram
LinkedIn

Donate
Accessibility
Privacy Policy
Terms of Use

Close Menu

Lymphoma
Patient Experience
Resources
News & Events
Get Involved
Ways to Give
About Us
Know Your Nodes

EN
FR
Contact Us
Donate

Research

Health Canada Approves ibrutinib for Mantle Cell Lymphoma

Search

Recent Posts

Are you a patient?

Are you a healthcare professional?

Contact Us

Donate

Join Our Mailing List